Liothyronine Sodium Strides Pharma (Liothyronine Sodium)

Liothyronine Sodium is a synthetic form of the active thyroid hormone triiodothyronine (T3). After oral absorption, it binds to nuclear thyroid hormone receptors, influencing gene transcription that regulates basal metabolic rate, protein synthesis, and heat production, thereby correcting the metabolic deficits of hypothyroidism.

The dosage of Liothyronine Sodium is individualized. A qualified prescriber determines the appropriate strength and frequency based on the patient’s clinical condition, laboratory results, age, weight, and comorbidities. Patients should follow the prescribing clinician’s instructions and not adjust the dose on their own.

Safety data for Liothyronine Sodium in pregnancy and lactation are limited. It should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers usually prefer the most appropriate thyroid hormone regimen and monitor maternal and fetal thyroid status closely.

To order Liothyronine Sodium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Liothyronine Sodium (T3) is the active form of thyroid hormone, while levothyroxine (T4) is a pro‑hormone that is converted to T3 in the body. T3 has a faster onset of action and a shorter half‑life, making it useful for rapid replacement, whereas levothyroxine provides more stable, long‑term hormone levels. Choice of therapy depends on clinical goals and patient response.

Liothyronine Sodium tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Liothyronine Sodium is taken orally, usually with a glass of water. It may be prescribed to be taken on an empty stomach or with food, depending on the prescriber’s guidance. Patients should follow the exact timing and dosing instructions provided by their healthcare professional.

Serious risks include cardiac arrhythmias, angina, myocardial infarction, severe bone loss (osteoporosis), anaphylactic reactions, and hepatic dysfunction. Patients with pre‑existing heart disease, osteoporosis, or liver disorders should be monitored closely, and any alarming symptoms should prompt immediate medical evaluation.

Liothyronine Sodium is contraindicated in patients with untreated adrenal insufficiency, acute myocardial infarction, or known hypersensitivity to the drug or its excipients. It should also be avoided in individuals where excessive thyroid hormone could exacerbate underlying conditions, unless a specialist determines that benefits outweigh the risks.